Agenus Inc. ( Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is ...
LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc., a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus ...
LEXINGTON, Mass., January 15, 2026--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration ...
Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results